Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.32 |
| ▸ | RELA | Q04206 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | MIF | P14174 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7865780 | 1.00 | KMT2A (0.33) | KMT2ANFKB1NFKB2RELATDP1 | |
| SCHEMBL206812 | 1.00 | KMT2A (0.33) | KMT2ANFKB1NFKB2RELATDP1 | |
| Sulfuric Acid SCHEMBL28494040 | 0.94 | CA12 (0.33) | KMT2ATDP1MAOAMAOBCA1 | |
| SCHEMBL2342887 | 0.86 | KMT2A (0.33) | KMT2ANFKB1NFKB2RELATDP1 | |
| SCHEMBL21359614 | 0.86 | DGAT1 (0.31) | DGAT1 | |
| SCHEMBL2823978 | 0.86 | KMT2A (0.33) | KMT2ANFKB1NFKB2RELATDP1 | |
| SCHEMBL2342888 | 0.86 | KMT2A (0.33) | KMT2ANFKB1NFKB2RELATDP1 | |
| SCHEMBL21359615 | 0.86 | DGAT1 (0.31) | DGAT1 | |
| SCHEMBL15177020 | 0.84 | KMT2A (0.33) | KMT2ANFKB1NFKB2RELATDP1 | |
| SCHEMBL14535778 | 0.84 | APLNR (0.38) | KMT2ATDP1CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1225 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119162691-B | Waterproof antibacterial polyester fiber fabric and preparation method thereof | 南通洁万家纺织有限公司 | 2025-05-13 | — | — | CN | claimed |
| US-12285501-B2 | Compound targeting norepinephrine transporter | Higuchi, Takahiro (DE) | 2025-04-29 | — | — | US | claimed |
| CN-119698421-A | Process for preparing tetrodotoxin and analogues thereof | 北京生命科学研究所 | 2025-03-25 | — | — | CN | claimed |
| CN-119371391-A | Aroyl compound and preparation method and application thereof | 河北医科大学 | 2025-01-28 | — | — | CN | claimed |
| CN-119162691-A | Waterproof antibacterial polyester fiber fabric and preparation method thereof | 南通洁万家纺织有限公司 | 2024-12-20 | — | — | CN | claimed |
| WO-2024032799-A1 | Preparation Method of Tetrodotoxin and its Analog | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2024-02-15 | — | — | WO | claimed |
| CN-113301926-B | Compounds targeting norepinephrine transporter | 北京雷鸟科技有限公司 | 2023-09-12 | — | — | CN | claimed |
| US-20230272006-A1 | PEPTIDOMIMETICS AND METHOD OF SYNTHESIS THEREOF | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2023-08-31 | — | — | US | claimed |
| US-20230100243-A1 | PEPTIDOMIMETICS AND METHOD OF SYNTHESIS THEREOF | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2023-03-30 | — | — | US | claimed |
| EP-3911372-B1 | COMPOUND TARGETING NOREPINEPHRINE TRANSPORTER | GUANGZHOU MIPHERE MEDICAL TECH CO LTD (CN) | 2022-11-30 | — | — | EP | claimed |
| US-6344466-B2 | ANTITHROMBOTIC ACTIVITY, USE IN INHIBITING LOSS OF BLOOD PLATELETS, INHIBITING FORMATION OF BLOOD PLATELET AGGREGATES, INHIBITING FORMATION OF FIBRIN, ANTICOAGULANTS | 3-DIMENSIONAL PHARMACEUTICALS INC. | 2002-02-05 | — | — | US | claimed |
| US-6344484-B1 | TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2002-02-05 | — | — | US | claimed |
| US-20010037039-A1 | Aminoguanidines and alkoxyguanidines as protease inhibitors | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2001-11-01 | — | — | US | claimed |
| US-20010031870-A1 | Benzamide and sulfonamide substitued aminoguanidines and alkoxyguanidines as protese inhibitors | SOLL RICHARD M (US) | 2001-10-18 | — | — | US | claimed |
| US-6235778-B1 | ANTICOAGULANTS | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2001-05-22 | — | — | US | claimed |
| EP-1070049-A1 | BENZAMIDE AND SULFONAMIDE SUBSTITUTED AMINOGUANIDINES AND ALKOXYGUANIDINES AS PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2001-01-24 | — | — | EP | claimed |
| EP-1012165-A1 | PROCESS FOR THE PREPARATION OF N-METHYL-D-PHENYLALANYL-N- 1- 3- (AMINOIMINOMETHYL)AMINO]PROPYL]-3,3-DIFLUORO-2-OXOHEXYL]-L-PROLINAMIDE | Aventis Pharmaceuticals Inc. (US) | 2000-06-28 | — | — | EP | claimed |
| WO-1999051571-A1 | BENZAMIDE AND SULFONAMIDE SUBSTITUTED AMINOGUANIDINES AND ALKOXYGUANIDINES AS PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 1999-10-14 | — | — | WO | claimed |
| US-5739354-A | ONE-STEP GUANYLATION OF 9,6-DIAMINO-5-HYDROXY-4,4-DIFLUORONONANE OR SALT; SIMPLIFICATION, HIGH YIELD END PRODUCT | HOECHST MARION ROUSSEL, INC. (US) | 1998-04-14 | — | — | US | claimed |
| WO-1997035874-A1 | PROCESS FOR THE PREPARATION OF N-METHYL-D-PHENYLALANYL-N-[1-[3-[(AMINOIMINOMETHYL)AMINO]PROPYL]-3,3-DIFLUORO-2-OXOHEXYL]-L-PROLINAMIDE | HOECHST MARION ROUSSEL, INC. (US) | 1997-10-02 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230100243-A1 | PEPTIDOMIMETICS AND METHOD OF SYNTHESIS THEREOF | GMPS, PAM, SRM | KMT2A 3273/4885NFKB1 2460/4885NFKB2 3537/4885 |
| US-12285501-B2 | Compound targeting norepinephrine transporter | SLC6A2, SLC18A2, SLC6A3 | KMT2A 2778/4885NFKB1 3578/4885NFKB2 3618/4885 |
| US-20010037039-A1 | Aminoguanidines and alkoxyguanidines as protease inhibitors | F9, PLG, MMP9 | KMT2A 2438/4885NFKB1 3735/4885NFKB2 4068/4885 |
| US-20230272006-A1 | PEPTIDOMIMETICS AND METHOD OF SYNTHESIS THEREOF | GMPS, PAM, SRM | KMT2A 3273/4885NFKB1 2460/4885NFKB2 3537/4885 |
| US-20010031870-A1 | Benzamide and sulfonamide substitued aminoguanidines and alkoxyguanidines as protese inhibitors | PLG, F9, TFPI | KMT2A 994/4885NFKB1 4154/4885NFKB2 4507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.